or
forgot password
  • cancer clinical trials in kalispell, MT

  • Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Glacier Oncology, PLLC
    Colorectal Cancer
    S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Leukemia
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Recurrent Mantle Cell Lymphoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Metastatic Cancer, Prostate Cancer
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Lymphoma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Breast Cancer